Search Results 981-990 of 12045 for Lupus
Active or history of autoimmune disease or immune deficiency, including, but not limited to, myasthenia gravis, myositis, autoimmune hepatitis, systemic lupus ...
Secondary forms of IgAN, indicated by the presence of any other systemic disease potentially leading to IgA deposits (e.g., Lupus nephritis, Schönlein ...
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Overview.
The purpose of this study is to determine the response rate to the combination of pembrolizumab and NT-I7 in patients with recurrent glioblastoma. Participation ...
This study will establish in vivo and ex vivo methodologies of assessing the utilization of extracellular nutrients by normal bone marrow plasma cells from ...
More common · Back pain · bloating or swelling of the face, arms, hands, lower legs, or feet · chest tightness · blurred vision · chills · clay-colored stools ...
... lupus anticoagulant (obtained =\< 30 days prior to registration) * Calculated creatinine clearance must be \>= 30 ml/min using the Cockcroft-Gault formula ...
Melanoma is the most serious form of skin cancer, and it's becoming more common. Learn more from the Melanoma and Skin Cancer Research Program at Mayo ...
Lumasiran injection is used to treat primary hyperoxaluria (high oxalic acid in the urine) type 1 (PH1) to lower oxalic acid in the urine and blood.
The research of Jonas Paludo, M.D., focuses on lymphoid malignancies, with a special interest in Waldenstrom macroglobulinemia and mantle cell lymphoma — two ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.